| Delays in breast cancer care by race and sexual orientation: results from a national survey with diverse women in the United States TC Poteat, MA Adams, J Malone, S Geffen, N Greene, M Nodzenski, ... Cancer 127 (19), 3514-3522, 2021 | 33 | 2021 |
| Surveillance for Guillain-Barré syndrome after 2015–2016 and 2016–2017 influenza vaccination of Medicare beneficiaries DP Arya, MA Said, HS Izurieta, S Perez-Vilar, C Zinderman, M Wernecke, ... Vaccine 37 (43), 6543-6549, 2019 | 22 | 2019 |
| Prevalence of lung cancer screening in the US, 2022 LM Henderson, IH Su, MP Rivera, J Pak, X Chen, DS Reuland, JL Lund JAMA Network Open 7 (3), e243190-e243190, 2024 | 4 | 2024 |
| Nondifferential treatment misclassification biases toward the null? Not a safe bet for active comparator studies RK Ross, IH Su, M Webster-Clark, M Jonsson Funk American journal of epidemiology 191 (11), 1917-1925, 2022 | 2 | 2022 |
| Use of Sensitivity Analyses to Assess Uncontrolled Confounding from Unmeasured Variables in Observational, Active Comparator Pharmacoepidemiologic Studies: A Systematic Review CD Latour, M Delgado, IH Su, C Wiener, CO Acheampong, C Poole, ... American Journal of Epidemiology, kwae234, 2024 | 1 | 2024 |
| Development and Evaluation of a Multisource Approach to Extend Mortality Follow-Up for Older Adults With Advanced Cancer Enrolled in Randomized Trials JL Lund, J Cacciatore, R Tylock, IH Su, S Sharma, SP Hinton, S Smith, ... JCO Clinical Cancer Informatics 8, e2300183, 2024 | 1 | 2024 |
| Regarding “Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs” IH Su, JL Lund, CE Gaber, HK Sanoff, PD Strassle, ED Duchesneau The Oncologist 28 (7), e588-e589, 2023 | 1 | 2023 |
| Hazard Ratios and Alternative Effect Measures: An Applied Illustration CD Latour, IH Su, M Delgado, V Pate, C Poole, JK Edwards, T Stürmer, ... Pharmacoepidemiology and Drug Safety 33 (9), e5885, 2024 | | 2024 |
| Estimating the effects of cancer screening in clinical practice settings: The role of selective uptake and suboptimal adherence along the cancer screening continuum JL Lund, MP Rivera, IH Su, JM Long, X Chen, J Pak, MG Hudgens, ... Cancer Epidemiology, Biomarkers & Prevention 33 (8), 984-988, 2024 | | 2024 |
| Predicting life expectancy in older adults with advanced cancer using geriatric assessment IH Su, R Tylock, J Cacciatore, S Cole, P Duberstein, L Hanson, SP Hinton, ... Journal of Geriatric Oncology 14 (8), S16-S17, 2023 | | 2023 |
| A hierarchical approach to death ascertainment for older adults with advanced cancer enrolled in clinical trials in the United States J Lund, RG Tylock, S Sharma, M Wells, P Duberstein, LC Hanson, ... Journal of Geriatric Oncology 13 (8), S73, 2022 | | 2022 |
| Risk ratios versus hazard ratios in comparative effectiveness research: An illustration using clinical trial data C Latour, I Su, M Delgado, V Pate, C Poole, J Edwards, T Sturmer, J Lund, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 16-16, 2022 | | 2022 |
| Selective sampling: A novel approach to simulating biased samples for methods research M Delgado, C Latour, I Su, V Pate, C Poole, J Edwards, T Sturmer, J Lund, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 562-562, 2022 | | 2022 |
| Comparing the effects of neoadjuvant versus adjuvant chemotherapy in stage II-III, triple-negative breast cancer: Illustration of trial emulation using the clone-censor-weight … I Su, C Gaber, S Downs-Canner, E Duchesneau, J Lund PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 44-45, 2022 | | 2022 |
